Please use this identifier to cite or link to this item:
https://hdl.handle.net/11055/604
Title: | Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial. | Authors: | Myles, PS Leslie, K McNeil, J Forbes, A Chan, MTV |
Issue Date: | May-2004 | Source: | 363(9423):1757-63. | Abstract: | BACKGROUND: Awareness is an uncommon complication of anaesthesia, affecting 0.1-0.2% of all surgical patients. Bispectral index (BIS) monitoring measures the depth of anaesthesia and facilitates anaesthetic titration. In this trial we determined whether BIS-guided anaesthesia reduced the incidence of awareness during surgery in adults. METHODS: We did a prospective, randomised, double-blind, multicentre trial. Adult patients at high risk of awareness were randomly allocated to BIS-guided anaesthesia or routine care. Patients were assessed by a blinded observer for awareness at 2-6 h, 24-36 h, and 30 days after surgery. An independent committee, blinded to group identity, assessed every report of awareness. The primary outcome measure was confirmed awareness under anaesthesia at any time. FINDINGS: Of 2463 eligible and consenting patients, 1225 were assigned to the BIS group and 1238 to the routine care group. There were two reports of awareness in the BIS-guided group and 11 reports in the routine care group (p=0.022). BIS-guided anaesthesia reduced the risk of awareness by 82% (95% CI 17-98%). INTERPRETATION: BIS-guided anaesthesia reduces the risk of awareness in at-risk adult surgical patients undergoing relaxant general anaesthesia. With a cost of routine BIS monitoring at US16 dollars per use in Australia and a number needed to treat of 138, the cost of preventing one case of awareness in high-risk patients is about 2200 dollars. | URI: | http://hdl.handle.net/11055/604 |
Appears in Collections: | Scholarly and Clinical |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.